CD30 CAR-T in the Treatment of CD30 Positive Relapsed/Refractory Lymphoma

Clinical trial NCT06850285 · RECRUITING

Trial details

NCT number: NCT06850285
Sponsor: Shanxi Bethune Hospital
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Lymphoma, B-Cell

Start date: 2025-09-05
Primary completion: 2028-06-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.